{
    "2018-12-09": [
        [
            {
                "time": "",
                "original_text": "机构看好黄金、光伏板块，资金加仓这些股（名单）",
                "features": {
                    "keywords": [
                        "黄金",
                        "光伏",
                        "资金加仓"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "黄金",
                        "光伏"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-12-09",
                "original_text": "【山证医药】医药行业周报（20181209）：带量采购超预期，仿制药行业将变天",
                "features": {
                    "keywords": [
                        "医药",
                        "带量采购",
                        "仿制药",
                        "超预期"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-09",
                "original_text": "首次带量采购落地，继续重点看好特色原料药、制剂出口、创新药等领域的投资机会【周观点|长江医药1209】",
                "features": {
                    "keywords": [
                        "带量采购",
                        "特色原料药",
                        "制剂出口",
                        "创新药",
                        "投资机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "原料药",
                        "制剂出口",
                        "创新药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "带量采购引发医药股“雪崩” 2019年行业板块将如何演绎",
                "features": {
                    "keywords": [
                        "带量采购",
                        "医药股",
                        "雪崩"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2019年度策：坚守创新企业迎产业变局",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新",
                        "产业变局"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物",
                        "创新"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药板块的“至暗时刻”！“4+7”带量采购降价幅度远超市场预期！恒瑞医药蒸发百亿",
                "features": {
                    "keywords": [
                        "医药板块",
                        "4+7",
                        "带量采购",
                        "降价",
                        "恒瑞医药"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}